Your browser doesn't support javascript.
loading
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.
Coll-Mulet, Llorenç; Iglesias-Serret, Daniel; Santidrián, Antonio F; Cosialls, Ana M; de Frias, Mercè; Castaño, Esther; Campàs, Clara; Barragán, Montserrat; de Sevilla, Alberto Fernández; Domingo, Alicia; Vassilev, Lyubomir T; Pons, Gabriel; Gil, Joan.
Affiliation
  • Coll-Mulet L; Departament de Ciències Fisiològiques II, IDIBELL-Universitat de Barcelona, Campus de Bellvitge, Pavelló de Govern, 4a planta, E-08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Blood ; 107(10): 4109-14, 2006 May 15.
Article in En | MEDLINE | ID: mdl-16439685
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins c-mdm2 / Antineoplastic Agents Limits: Humans Language: En Journal: Blood Year: 2006 Document type: Article Affiliation country: Spain Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins c-mdm2 / Antineoplastic Agents Limits: Humans Language: En Journal: Blood Year: 2006 Document type: Article Affiliation country: Spain Country of publication: United States